ER+ Breast Cancer Strongly Depends on MCL-1 and BCL-xL Anti-Apoptotic Proteins

ER+ Breast Cancer Strongly Depends on MCL-1 and BCL-xL Anti-Apoptotic Proteins

Breast cancer is the most frequent type of cancer and the major cause of mortality in women. The rapid development of various therapeutic options has led to the improvement of treatment outcomes; nevertheless, one-third of estrogen receptor (ER)-positive patients relapse due to cancer cell acquired...

Full description

Bibliographic Details
Main Authors: Clara Alcon, Jorge Gómez Tejeda Zañudo, Reka Albert, Nikhil Wagle, Maurizio Scaltriti, Anthony Letai, Josep Samitier, Joan Montero
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Cells
Subjects:
ER+ breast cancer
DBP
priming
apoptosis
targeted therapies
resistance
Online Access:https://www.mdpi.com/2073-4409/10/7/1659

Internet

https://www.mdpi.com/2073-4409/10/7/1659

Similar Items